Senior Global Access Evidence Leader EU HTA Statistician

At Roche you can show up as yourself embraced for the unique qualities you bring. Our culture encourages personal expression open dialogue and genuine connections where you are valued accepted and respected for who you are allowing you to thrive both personally and professionally. This is how we aim to prevent stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche where every voice matters.

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference.

Within GPS the Global Access (GA) department is dedicated to delivering sustainable replicable and scalable global strategies policies and solutions. Our mission is to support the Pharma Vision enabling affiliates to drive patient access locally while improving value for society healthcare ecosystems and Roches business. We operate in a highly networked and agile model with stable chapters and flexible squads and work teams across the product lifecycle disease areas functions and geographies with chapters built around the expertise and capabilities needed to co-create and deliver integrated solutions.

Role Overview

We are seeking a dynamic and visionary Senior Global Access Evidence Leader with deep EU HTA and advanced statistical and evidence-synthesis expertise to join our Evidence Chaptera professional recognized within the European HTA community for advancing evidence standards and shaping submissions that secure patient access across EU member this role you will thrive in a collaborative environment and be passionate about making a difference.

• Lead EU HTA evidence strategy: Shape Roches approach to EU HTA submissions by embedding sophisticated anticipatory evidence strategies into clinical development from inception ensuring alignment with EMA regulations and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets.

• Drive methodological innovation in EU contexts: Leverage your established networks within European HTA bodies payers and health authorities to advance evidence standards and best practicesinfluencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks.

• Architect compelling EU submissions: Design innovative region-specific evidence packages that anticipate the needs of EMA committees HTA bodies and national payers. Identify strategic evidence gaps early pioneer novel data sources and analyses and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets.

• Establish Roche as an EU HTA expert: Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality engage proactively with key opinion leaders and HTA bodies and position Roche as a thought leader in EU evidence generation and submission strategy.

• Lead strategic statistical analysis for EU evidence packages: Lead and critically evaluate complex statistical analysesincluding network meta-analyses and real-world evidence synthesesensuring methodological rigor and compliance with EU HTA requirements while translating findings into compelling region-appropriate narratives.

• Enable affiliates and cross-functional teams: Guide European affiliate teams and cross-functional partners in building robust EU submission strategies ensure alignment across EMA development pathways and national HTA submissions and mentor colleagues on evolving EU regulatory and HTA landscapes.

• Contribute to EU HTA evolution: Maintain influential engagement with European HTA bodies regulatory agencies and academic networksactively participating in professional forums contributing to methodological debates and ensuring Roche remains at the forefront of EU evidence standards and innovation.

• Advanced expertise & experience in EU HTA: You hold a Masters or Doctoral-level degree in applied statistics and bring 12 years of deep hands-on experience in the pharmaceutical industry health economics/HTA consultancy European payer organizations EMA-regulated environments or academic research with progressive strategic influence in European markets.

• Recognized standing in the European HTA community: You are a known voice actively engaged with European HTA networks national HTA bodies or equivalent professional networks holding established relationships with key opinion leaders and contributing to methodological discussions through publications conference presentations or advisory roles.

• Deep knowledge of the EU HTA landscape: You demonstrate a thorough understanding of the EU HTA Regulation (2021/2282) and joint clinical assessment procedures national HTA requirements across major European markets (UK Germany France Italy Spain etc.) EMA scientific advice and conditional approval pathways and real-world evidence requirements in EU contexts.

• Master-level statistical expertise & strategic vision: You possess mastery of advanced statistical methods (Generalized Linear Models Survival Analysis Network Meta-Analysis Bayesian methods real-world evidence analyses) using R and contemporary tools (GitLab SAS Python WinBUGS JAGS) paired with the ability to think strategically about EU market access and nuances across European healthcare systems.

• Collaborative leadership & exceptional communication: You excel at leading cross-functional teams in matrix environments engaging with European affiliate teams and external HTA bodies and possess outstanding written and verbal communication skills in English (and ideally German French or other European languages) to translate technical analyses into compelling narratives.

Ready for the next step We look forward to hearing from you. Apply now to discover this exciting opportunity!

A healthier future drives us to innovate. Together more than 100000 employees across the globe are dedicated to advance science ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities foster creativity and keep our ambitions high so we can deliver life-changing healthcare solutions that make a global impact.

Lets build a healthier future together.

Roche is an Equal Opportunity Employer.